X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (155197) 155197
Publication (19063) 19063
Book Chapter (1404) 1404
Book Review (1314) 1314
Newsletter (1310) 1310
Conference Proceeding (576) 576
Newspaper Article (299) 299
Magazine Article (289) 289
Dissertation (279) 279
Government Document (47) 47
Book / eBook (39) 39
Streaming Video (23) 23
Data Set (11) 11
Transcript (10) 10
Web Resource (10) 10
Paper (8) 8
Reference (7) 7
Trade Publication Article (6) 6
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84443) 84443
animals (55339) 55339
index medicus (43285) 43285
male (33825) 33825
female (32500) 32500
mice (26425) 26425
biochemistry & molecular biology (25787) 25787
trans-activators - metabolism (23844) 23844
trans-activators - genetics (20746) 20746
expression (18723) 18723
middle aged (17932) 17932
cell biology (16163) 16163
molecular sequence data (15138) 15138
aged (14514) 14514
adult (13889) 13889
dna-binding proteins - metabolism (11856) 11856
research (11416) 11416
base sequence (11084) 11084
signal transduction (11035) 11035
cells, cultured (10859) 10859
gene expression (10693) 10693
cell line (10591) 10591
proteins (10585) 10585
rats (10467) 10467
plasminogen-activator (10177) 10177
amino acid sequence (9857) 9857
oncology (9720) 9720
gene-expression (9396) 9396
peripheral vascular disease (9343) 9343
hematology (8769) 8769
analysis (8727) 8727
dna-binding proteins - genetics (8533) 8533
tissue plasminogen activator (8471) 8471
phosphorylation (8276) 8276
time factors (8172) 8172
mutation (8058) 8058
transcription factors (8055) 8055
transcription factors - metabolism (7868) 7868
gene (7827) 7827
promoter regions, genetic (7658) 7658
protein (7652) 7652
protein binding (7633) 7633
tissue plasminogen activator - therapeutic use (7576) 7576
thrombolytic therapy (7441) 7441
stroke (7376) 7376
transcription, genetic (7111) 7111
cells (7046) 7046
transcription factors - genetics (6922) 6922
genetic aspects (6864) 6864
trans-activators (6816) 6816
fibrinolysis (6724) 6724
activation (6722) 6722
transfection (6452) 6452
treatment outcome (6437) 6437
binding sites (6375) 6375
article (6292) 6292
physiological aspects (6291) 6291
cancer (6274) 6274
research article (6241) 6241
thrombolysis (6183) 6183
trans-activators - physiology (6171) 6171
microbiology (6150) 6150
immunology (6142) 6142
clinical neurology (6135) 6135
apoptosis (5967) 5967
neurosciences (5883) 5883
tissue-plasminogen activator (5851) 5851
genes (5757) 5757
fibrinolytic agents - therapeutic use (5680) 5680
genetics & heredity (5658) 5658
gene expression regulation (5615) 5615
transcription (5572) 5572
pharmacology & pharmacy (5509) 5509
aged, 80 and over (5490) 5490
risk factors (5490) 5490
rna, messenger - metabolism (5461) 5461
transcriptional activation (5437) 5437
cell line, tumor (5362) 5362
multidisciplinary sciences (5326) 5326
cardiac & cardiovascular systems (5300) 5300
mice, inbred c57bl (5218) 5218
immunohistochemistry (5199) 5199
tumor cells, cultured (5122) 5122
activators (5056) 5056
endocrinology & metabolism (4915) 4915
activator (4863) 4863
differentiation (4829) 4829
identification (4779) 4779
binding (4676) 4676
inflammation (4550) 4550
in-vivo (4511) 4511
medicine, research & experimental (4445) 4445
health aspects (4421) 4421
in-vitro (4371) 4371
developmental biology (4346) 4346
kinetics (4298) 4298
rna, messenger - genetics (4249) 4249
blotting, western (4219) 4219
therapy (4198) 4198
biotechnology & applied microbiology (4159) 4159
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Dentistry (Harry R Abbott) - Stacks (6) 6
Online Resources - Online (6) 6
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (151972) 151972
Japanese (2601) 2601
German (1419) 1419
Chinese (1373) 1373
French (836) 836
Russian (682) 682
Spanish (491) 491
Polish (274) 274
Italian (272) 272
Korean (207) 207
Portuguese (92) 92
Czech (80) 80
Turkish (73) 73
Dutch (44) 44
Danish (42) 42
Hungarian (40) 40
Ukrainian (33) 33
Swedish (24) 24
Norwegian (20) 20
Croatian (19) 19
Romanian (16) 16
Slovak (14) 14
Bulgarian (13) 13
Persian (13) 13
Finnish (12) 12
Serbian (12) 12
Greek (8) 8
Hebrew (7) 7
Indonesian (6) 6
Arabic (3) 3
Icelandic (3) 3
Thai (2) 2
Bosnian (1) 1
Catalan (1) 1
Lithuanian (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular Biochemistry, ISSN 0730-2312, 01/2018, Volume 119, Issue 1, pp. 17 - 27
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3251 - 3264
The neurovascular unit provides a dynamic interface between the circulation and central nervous system. Disruption of neurovascular integrity occurs in... 
traumatic brain injury | matrix metalloproteinase-3 | plasminogen activator inhibitor-1 | tissue plasminogen activator | neurovascular unit | MULTIPLE-SCLEROSIS LESIONS | RECEPTOR-RELATED PROTEIN | TPA | FOCAL CEREBRAL-ISCHEMIA | BARRIER BREAKDOWN | NEUROSCIENCES | CLINICAL NEUROLOGY | STROKE | MATRIX METALLOPROTEINASES | CENTRAL-NERVOUS-SYSTEM | EXPRESSION | BLOOD | Capillary Permeability - physiology | Tissue Plasminogen Activator - metabolism | Brain Injuries - drug therapy | Humans | Middle Aged | Injections, Intraventricular | Capillary Permeability - drug effects | Male | Brain Injuries - metabolism | Brain Injuries - physiopathology | Plasminogen Activator Inhibitor 1 - physiology | Matrix Metalloproteinase Inhibitors - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | Tissue Plasminogen Activator - antagonists & inhibitors | Plasminogen Activator Inhibitor 1 - metabolism | Aged, 80 and over | Recovery of Function - physiology | Adult | Disease Models, Animal | Albumins - metabolism | Mice, Inbred C57BL | Plasminogen Activator Inhibitor 1 - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - physiology | Animals | Brain Injuries - cerebrospinal fluid | Aged | Mice | Matrix Metalloproteinases - metabolism | Stroke | Central nervous system | Membrane permeability | Albumin | Homeostasis | Cerebrospinal fluid | Matrix metalloproteinase | Permeability | Trauma | Plasmin | t-Plasminogen activator | lipoprotein receptors | neuroserpin | plasminogen | Proteolysis | Plasma membranes | Chromium | Serine proteinase | Brain injury | Original
Journal Article
Biochemical Journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 2, pp. 203 - 210
PAI-I and PAI-2 (plasminogen-activator inhibitor types I and 2) are inhibitors of cell surface upA (urokinase plasminogen activator). However, tumour... 
Serpin (serine protease inhibitor) | Plasminogen-activator inhibitor type 2 (PAI-2) | Urokinase plasminogen activator (uPA) | Very-low-density lipoprotein receptor (VLDLr) | Plasminogen-activator inhibitor type 1 (PAI-1) | SYSTEM | very-low-density lipoprotein receptor (VLDLr) | PROTEIN | LDL RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | plasminogen-activator inhibitor type 1 (PAI-1) | serpin (serine protease inhibitor) | urokinase plasminogen activator (uPA) | COMPLEX-FORMATION | RAP COMPLEX | plasminogen-activator inhibitor type 2 (PAI-2) | DENSITY-LIPOPROTEIN-RECEPTOR | UROKINASE RECEPTOR | BINDING-SITE | LIGAND | Humans | Receptors, Cell Surface - metabolism | Receptors, LDL - metabolism | Plasminogen Activator Inhibitor 2 - physiology | Plasminogen Activator Inhibitor 1 - physiology | Breast Neoplasms - metabolism | Receptors, Urokinase Plasminogen Activator | Breast Neoplasms - chemistry | Plasminogen Activator Inhibitor 1 - chemistry | Plasminogen Activator Inhibitor 1 - metabolism | Urokinase-Type Plasminogen Activator - metabolism | Breast Neoplasms - pathology | Plasminogen Activator Inhibitor 2 - metabolism | Protein Structure, Secondary - physiology | Signal Transduction - physiology | Urokinase-Type Plasminogen Activator - chemistry | Tumor Cells, Cultured | Plasminogen Activator Inhibitor 2 - chemistry | Protein Binding - physiology | Protein Structure, Tertiary - physiology | uPA, urokinase plasminogen activator | LDLR, low-density lipoprotein receptor | serpin, serine protease inhibitor | uPAR, urokinase plasminogen activator receptor | VLDLr, very-low-density lipoprotein receptor | PAI, plasminogen-activator inhibitor | RAP, receptor-associated protein | RCL, reactive centre loop | ERK, extracellular-signal-regulated kinase | plasminogen-activator inhibitor type 1 (PAI-1) | LRP, low-density lipoprotein receptor-related protein | SPR, surface plasmon resonance | plasminogen-activator inhibitor type 2 (PAI-2)
Journal Article
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 03/2017, Volume 45, Issue 6, pp. 805 - 815
Glutamate phase shifts the circadian clock in the mammalian suprachiasmatic nucleus (SCN) by activating NMDA receptors. Tissue‐type plasminogen activator (tPA)... 
urokinase‐type plasminogen activator | circadian rhythms | suprachiasmatic nucleus | tissue‐type plasminogen activator | urokinase-type plasminogen activator | tissue-type plasminogen activator | NEURONAL MIGRATION | CELL-ADHESION MOLECULE | NEUROTROPHIC FACTOR | RECEPTOR | NEUROSCIENCES | IN-VITRO | EXTRACELLULAR-MATRIX | BIOLOGICAL CLOCK | BRAIN | GENE-FUNCTION | Brain-Derived Neurotrophic Factor - genetics | Suprachiasmatic Nucleus - drug effects | Tissue Plasminogen Activator - metabolism | Mice, Inbred C57BL | Plasminogen Inactivators - pharmacology | Male | Tissue Plasminogen Activator - genetics | Suprachiasmatic Nucleus - physiology | Animals | Urokinase-Type Plasminogen Activator - metabolism | Proteolysis | Circadian Clocks | Female | Suprachiasmatic Nucleus - metabolism | Brain-Derived Neurotrophic Factor - metabolism | Mice | Urokinase | Glutamate | Tissue plasminogen activator | Laws, regulations and rules | Suprachiasmatic nucleus | Glutamic acid | Brain | Night | Glutamic acid receptors (ionotropic) | Brain slice preparation | Nuclei | Phase transitions | Plasmin | t-Plasminogen activator | Receptors | Casein | Rodents | Entrainment | Inhibition | Biological clocks | Circadian rhythms | Phase shift | Polyamide-imides | N-Methyl-D-aspartic acid receptors | Circadian rhythm | Mammals | U-Plasminogen activator | Brain-derived neurotrophic factor | Inhibitors | Plasminogen activator inhibitors | TrkB receptors | Glutamatergic transmission | Gates
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 24, pp. 2285 - 2295
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 01/2013, Volume 85, Issue 2, pp. 216 - 222
Journal Article
Biochemistry, ISSN 0006-2960, 03/2017, Volume 56, Issue 12, pp. 1768 - 1784
Journal Article